Marshall Wace, LLP Blueprint Medicines Corp Transaction History

Marshall Wace, LLP

  • $72.2 Billion
  • Q2 2024

A detailed history of Marshall Wace, LLP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 351,756 shares of BPMC stock, worth $32.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
351,756
Previous 230,292 52.74%
Holding current value
$32.5 Million
Previous $21.8 Million 73.55%
% of portfolio
0.05%
Previous 0.03%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$85.18 - $108.78 $10.3 Million - $13.2 Million
121,464 Added 52.74%
351,756 $37.9 Million
Q1 2024

May 15, 2024
BUY
$73.17 - $99.79 $16.9 Million - $23 Million
230,292 New
230,292 $21.8 Million
Q4 2022

Feb 14, 2023
BUY
$41.06 - $66.48 $21.7 Million - $35.2 Million
529,456 New
529,456 $23.2 Million
Q2 2022

Aug 15, 2022
SELL
$45.23 - $70.15 $8.44 Million - $13.1 Million
-186,600 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$54.1 - $110.08 $41.3 Million - $84.1 Million
-764,082 Reduced 80.37%
186,600 $11.9 Million
Q4 2021

Feb 14, 2022
BUY
$94.25 - $115.99 $87 Million - $107 Million
923,577 Added 3407.4%
950,682 $102 Million
Q3 2021

Nov 15, 2021
SELL
$80.98 - $109.47 $970,221 - $1.31 Million
-11,981 Reduced 30.65%
27,105 $2.79 Million
Q2 2021

Aug 13, 2021
BUY
$82.78 - $101.0 $3.24 Million - $3.95 Million
39,086 New
39,086 $3.44 Million
Q1 2021

May 17, 2021
SELL
$90.71 - $108.28 $330,365 - $394,355
-3,642 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$92.08 - $124.48 $23.7 Million - $32 Million
-257,260 Reduced 98.6%
3,642 $408,000
Q3 2020

Nov 16, 2020
BUY
$66.45 - $92.7 $15.8 Million - $22.1 Million
238,042 Added 1041.3%
260,902 $24.2 Million
Q2 2020

Aug 13, 2020
SELL
$57.09 - $79.27 $10.7 Million - $14.9 Million
-188,146 Reduced 89.17%
22,860 $1.78 Million
Q1 2020

May 15, 2020
BUY
$48.11 - $82.22 $9.82 Million - $16.8 Million
204,103 Added 2956.73%
211,006 $12.3 Million
Q4 2019

Feb 14, 2020
BUY
$66.73 - $82.59 $460,637 - $570,118
6,903 New
6,903 $553,000
Q1 2019

May 14, 2019
SELL
$48.7 - $86.6 $420,524 - $747,791
-8,635 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$45.57 - $74.26 $6.37 Million - $10.4 Million
-139,699 Reduced 94.18%
8,635 $466,000
Q3 2018

Nov 14, 2018
BUY
$58.91 - $78.32 $8.74 Million - $11.6 Million
148,334 New
148,334 $11.6 Million

Others Institutions Holding BPMC

# of Institutions
340
Shares Held
62M
Call Options Held
987K
Put Options Held
578K
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.52B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email